**7.4 Ethambutol**


Due to the fact that the new generation of fluoroquinolones (FQs), e.g., levofloxacin, ofloxacin, and moxifloxacin, have potent activity against most strains of M. tuberculosis and have excellent CSF penetration and safety profiles, they could be used as part of therapy first line for TBM [43].
